What Researchers Did
Researchers described two individual cases of patients with painful lower extremity ulcers from livedoid vasculopathy who received hyperbaric oxygen therapy (HBOT).
What They Found
The first patient, a 22-year-old female, received HBOT at 2.5 ATA for 1 hour daily, six days a week, and reported a drastic reduction in pain and halved her analgesic dose after ten sessions. The second patient, a 49-year-old male, experienced pain improvement by the 8th session and complete pain relief by the 17th session, along with improved walking.
What This Means for Canadian Patients
For Canadian patients suffering from the painful, recurrent ulcers of livedoid vasculopathy, this study suggests HBOT could be a potential treatment option, especially when other therapies have not worked. While not a common condition, HBOT might offer relief from severe pain and improve mobility for those affected.
Canadian Relevance
Livedoid vasculopathy is not a Health Canada-recognized indication for HBOT. No direct Canadian connection identified.
Study Limitations
This study is limited by being a case report of only two patients, which means the findings may not apply to a broader population.